AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026Net selling: insiders sold $2.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$2.7M netNet selling
- CongressSTOCK Act, last 180 days
- -$1K to -$15K netNet selling
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 2 cutEven
- Federal contractsUSAspending.gov, last 12 months
- 9 awardsAwards on record
Key stats
Fundamentals Sep 27- Open
- $157.68
- 52-wk high
- $165.79
- High
- $159.87
- 52-wk low
- $121.73
- Low
- $156.68
- Prev close
- $156.14
- Mkt cap
- $88.26B
- P/E
- 34.6x
- Volume
- 1.96M
- Fwd P/E
- 21.5x
- Beta
- 1.23
- Div yield
- 1.40%
- P/S
- 4.7x
- P/B
- 4.2x
- Profit margin
- +13.8%
- Op margin
- +26.9%
- ROE
- +12.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about EMR filings
Are insiders buying or selling Emerson Electric Company (EMR) stock?
Net selling: insiders sold $2.7M and bought $0 of EMR stock on the open market in the 90 days to Sep 27, 2026, according to SEC Form 4 filings. The largest was Karsanbhai, Surendralal Lanca (President & CEO), who sold $1.6M. The latest filing was on Aug 12, 2026.
Which members of Congress have traded EMR recently?
Rep. Richard Dean McCormick (R) sold $1K to $15K on Jul 30, 2026, disclosed 15 days later. In total, 1 member disclosed 1 EMR trade with trade dates in the last 180 days, filed a median 15 days after trading.
How current is this EMR smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- P7
Point72
$79.8M
bought
Sells/Trims (2)
- SQ
Squarepoint
$42.2M
trimmed
- BR
Bridgewater
$12.3M
trimmed
What insiders are doing
What Congress is doing
Buys (1)
Sells (1)
How top traders are positioned
No tracked top-trader positions in EMR right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 1.8% above what analysts expected.
Earnings per share
$1.68 expected
Revenue
No comparable estimate
Reports Nov 4, 2026, in 38 days
Estimates as of Sep 27, 2026
EPS expected
$1.61 to $1.87
Revenue expected
18 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.86B | $4.35B | $4.56B | $4.87B |
| Cost of what it sold | $2.34B | $2.04B | $2.14B | $2.22B |
| Gross profit | $2.52B | $2.31B | $2.42B | $2.65B |
| What it spent | ||||
| Sales and admin | $1.33B | $1.24B | $1.32B | $1.34B |
| Other operating costs | $207.0M | $205.0M | $205.0M | $311.0M |
| Total operating expenses | $1.54B | $1.45B | $1.52B | $1.65B |
| What was left | ||||
| Operating profit | $982.0M | $864.0M | $901.0M | $1.00B |
| Interest on debt | $242.0M | $116.0M | $110.0M | $85.0M |
| Profit before tax | $796.0M | $775.0M | $793.0M | $916.0M |
| Tax | $160.0M | $169.0M | $175.0M | $198.0M |
| Net profit | $636.0M | $605.0M | $618.0M | $718.0M |
| EBITDA | $1.42B | $1.25B | $1.27B | $1.21B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace